Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dedu Honghua Qiwei Powder for liver fibrosis
ChiCTR1800020394Phase 2Not yet recruiting
- Sponsor
- Affiliated Hospital of Inner Mongolia Medical University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Dedu Honghua Qiwei Powder and Fufang Biejia Ruangan in hepatic fibrosis (2 arms), sponsored by Affiliated Hospital of Inner Mongolia Medical University. Primary endpoint: Liver function index. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
Dedu Honghua Qiwei PowderFufang Biejia Ruangan
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR1800020394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020394.